Nektar Therapeutics
NKTRNASDAQ
Healthcare
Biotechnology
$77.01
+1.30(1.7%)
52W $7.36 – $76.99
Quick:
SCHEDULE 13G/A
Mar 27, 2026 (1 weeks ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-K
Mar 13, 2026 (3 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 12, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Mar 6, 2026 (1 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 13, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 13, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 10, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 10, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Jan 30, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 27, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 16, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 21, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Nov 13, 2025 (4 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 10, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 7, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 6, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Oct 31, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Oct 28, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active